Screening of interstitial lung disorders with a multidisciplinary approach: A comprehensive analysis of the empirical results and future prospects

Abstract

Author(s): Upendra Sharma Udayashankar Sulibele, V. C. Patil, Sridhar Pappu, Sanjay Bhatnagar, Dhwani Bartwal, Madhur Grover

Objective: A fundamental shift in the diagnostic strategy for diffuse lung illness was emphasized by the possibility of a Multidisciplinary Analysis (MDA) to identify interstitial pneumonia. This research offered a multidisciplinary screening method for interstitial lung disorders and a detailed analysis of current and past information. Material and Methods: These guidelines also emphasize the necessity of excluding lung involvement associated with connective tissue diseases, which has clear clinical and therapeutic implications. Result: The radiologist, pathologist, pulmonologist, rheumatologist and oncologists during lung cancer studies situations where pulmonary involvement could be the initial or most apparent sign of a systemic autoimmune illness to enhance diagnostic agreement and characterization. Interstitial Pneumonia including Autoimmune Features (IPAF) classification criteria aims to characterize lung participation specifically in unexplained autoimmune diseases. Due to the difficulty of autoimmune illness and the poor categorization standards regarding pathologies like anti-synthetase syndrome, rheumatologists must correctly interpret the autoimmune element and apply classification criteria to change the clinical images that were first perceived as IPAF in described autoimmune diseases, lowering the chance of a false positive. Conclusion: Rheumatologists can play a key role in identifying CTD-ILD or IPAF in MDA meetings. Typically, the MDA includes a pulmonologist, pathologist, and radiologist, with a focus on efficient evaluation and screening. The MDA approach also might be useful in ILD-progressed lung cancer patients, where ILD patients have an increased risk of the development of lung cancer.

Share this article